News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,023 Results
Type
Article (40818)
Company Profile (289)
Press Release (667916)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (206907)
Career Advice (2046)
Deals (35735)
Drug Delivery (98)
Drug Development (81913)
Employer Resources (174)
FDA (16227)
Job Trends (15038)
News (349276)
Policy (32828)
Tag
Academia (2583)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50319)
ALS (92)
Alzheimer's disease (1390)
Antibody-drug conjugate (ADC) (126)
Approvals (16233)
Artificial intelligence (258)
Autoimmune disease (21)
Automation (16)
Bankruptcy (363)
Best Places to Work (11706)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (213)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (279)
Cancer (2272)
Cardiovascular disease (173)
Career advice (1711)
Career pathing (30)
CAR-T (153)
Cell therapy (432)
Cervical cancer (19)
Clinical research (66645)
Collaboration (849)
Compensation (525)
Complete response letters (19)
COVID-19 (2615)
CRISPR (42)
C-suite (246)
Cystic fibrosis (100)
Data (2212)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (271)
Diagnostics (6402)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87124)
Editorial (38)
Employer branding (21)
Employer resources (148)
Events (115258)
Executive appointments (734)
FDA (17483)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (759)
Gene editing (106)
Generative AI (21)
Gene therapy (311)
GLP-1 (713)
Government (4439)
Grass and pollen (4)
Guidances (59)
Healthcare (18911)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (30)
Infectious disease (2758)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (99)
Interviews (315)
IPO (16621)
IRA (40)
Job creations (3746)
Job search strategy (1455)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7984)
Liver cancer (75)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (312)
MASH (66)
Medical device (13396)
Medtech (13401)
Mergers & acquisitions (19656)
Metabolic disorders (689)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1930)
NextGen: Class of 2025 (6583)
Non-profit (4509)
Now hiring (39)
Obesity (366)
Opinion (216)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (47)
People (58344)
Pharmaceutical (68)
Pharmacy benefit managers (18)
Phase I (20835)
Phase II (29394)
Phase III (21751)
Pipeline (1188)
Policy (140)
Postmarket research (2572)
Preclinical (8881)
Press Release (71)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (383)
Real estate (6071)
Recruiting (67)
Regulatory (22474)
Reports (46)
Research institute (2352)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (88)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3683)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (39)
The Weekly (30)
Vaccines (689)
Venture capitalists (42)
Weight loss (239)
Women's health (35)
Worklife (16)
Date
Today (174)
Last 7 days (880)
Last 30 days (2659)
Last 365 days (33236)
2025 (10743)
2024 (35641)
2023 (40431)
2022 (51638)
2021 (56111)
2020 (54480)
2019 (46909)
2018 (35347)
2017 (32526)
2016 (32053)
2015 (38032)
2014 (31812)
2013 (26847)
2012 (29162)
2011 (29834)
2010 (27936)
Location
Africa (748)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38787)
Australia (6470)
California (6168)
Canada (2013)
China (528)
Colorado (267)
Connecticut (277)
Delaware (148)
Europe (83911)
Florida (908)
Georgia (206)
Idaho (57)
Illinois (562)
India (25)
Indiana (307)
Iowa (11)
Japan (163)
Kansas (108)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (894)
Massachusetts (4624)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1741)
New Mexico (29)
New York (1750)
North Carolina (991)
North Dakota (8)
Northern California (2693)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1385)
Puerto Rico (12)
Rhode Island (33)
South America (1137)
South Carolina (22)
South Dakota (1)
Southern California (2312)
Tennessee (101)
Texas (913)
United States (23309)
Utah (183)
Virginia (147)
Washington D.C. (61)
Washington State (560)
West Virginia (3)
Wisconsin (55)
709,023 Results for "adverum biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
March 31, 2025
·
1 min read
Press Releases
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
April 16, 2025
·
10 min read
Press Releases
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2025
April 7, 2025
·
1 min read
Press Releases
Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
March 4, 2025
·
10 min read
Biotech Bay
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.
June 18, 2024
·
1 min read
Press Releases
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Press Releases
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 28, 2025
March 3, 2025
·
2 min read
Biotech Bay
Adverum Biotechnologies to Participate in Upcoming May 2024 Investor Conferences
Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, announced that the company will present at the following upcoming investor conferences.
May 3, 2024
·
1 min read
Business
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, reported financial results for the first quarter of 2024.
May 9, 2024
·
9 min read
1 of 70,903
Next
